A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
Clinical trial NCT04825860 · TERMINATED
Trial details
- NCT number
- NCT04825860
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2023-10-12
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.